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Autophagy has many roles in immunity, including the control of intracellular microbes by a cell-autonomous
mechanism. In this issue of Immunity, Shelly et al. (2009) use VSV infection in Drosophila to show the role of
autophagy genes in controlling viruses.Autophagy is important in many health and
disease processes, including aging,
metabolism, cancer, neurodegeneration,
immunity, and inflammatory illnesses. In
principle, autophagy is evolution’s answer
to the demands of keeping the cytoplasm
and complex organellar systems of the eu-
karyotic cells in good repair, with an added
bonus of nimble biomass adjustments in
response to growth factor withdrawal and
starvation. The key emblematic physical
manifestation of autophagy (executed by
the proteins termed Atg) that can be
morphologically observedunder themicro-
scope is the formation of autophagosomes
inside the cell’s cytoplasm. Autophago-
somes corral portions of the cytosol for
digestion in autolysosomes and reuse it at
times of starvation. They also capture
defectiveorobsoleteorganellesearmarked
for removal, such as leaky mitochondria,
surplus peroxisomes, excess endoplasmic
reticulum, etc. The metabolic aspects
of autophagy are under the negative
control by growth factors, insulin receptor
substrates, type I phosphatidylinositol
3 kinase (PI3K), Akt, Tor, andAtg1 signaling
cascades. Autophagic machinery is regu-
lated at yet another key node centered on
anancient stress-signaling enzyme, known
as type III PI3K VPS34, via its interacting
partner Beclin 1. Many signals affect these
two ‘‘nerve centers’’ of autophagic control.
In thecaseofBeclin1,stress inputssuchas
activation via JNK kinase, death-associ-
ated protein kinase, p14ARF agonist and
stabilizer of the tumor suppressor p53,
which in turn also regulates autophagy,
hypoxia response regulator HIF-1 via the
BH3-only protein Bnip3, and perhaps
even MyD88, an adaptor downstream of
many pattern recognition receptors
(PRRs), can lead to autophagy activation.The multitude of immune functions of
autophagy (Deretic, 2009), dubbed once
as ‘‘immunophagy,’’ encompass: (1)
peripheral and central tolerance including
thymicselectionalongwithMHC IIpresen-
tation of cytoplasm antigens; (2) homeo-
stasis of T cell, B cell, and other special-
ized immune cells, e.g., Paneth cells of
the intestinal crypts; (3) activation or
dampening of proinflammatory processes
including IL-1b and type I IFN production;
(4) effector output of Th1 and Th2 cell
polarization indefenseagainst intracellular
pathogens; (5) activation of PRR along
with carrying out antimicrobial effector
functions downstream of PRR stimulation;
and (6) cell-autonomous defense against
bacterial, protozoan, and viral pathogens.
In this issue, Shelly et al. (2009) touch
upon the points 5 and 6 from the above
list of the immunological functions of au-
tophagy. The processes studied by Shelly
et al. probably hark back to the evolution-
arily most ancient use of autophagy: to
apprehend and destroy by digestion the
microbial intruders that manage to erode
into the eukaryotic cell’s cytosol. A con-
founding roadblock to uncovering and
clearly demonstrating this primordial func-
tion of autophagy is that years of evolu-
tions stand in the way when one examines
finely tuned present-day host-pathogen
pairs. This is because more often than
not, the inherent ability ofmammalian cells
to efficiently deploy their antimicrobial
measures is masked by the countermea-
sures deployed by the highly adapted
microbes, either causing disease or
evolving all the way to commensalism.
The molecular underpinnings of this
problem are best illustrated in the exam-
ples of Shigella (Ogawa et al., 2005) and
herpes simplex virus type 1 (HSV-1) (Orve-Immunitdahl et al., 2007), both of which possess
highly evolved specific factors enabling
the microorganisms to efficiently evade
autophagy: Shigella virulence protein
IcsB blocks a specific bacterial epitope
that otherwise induces autophagy,
whereas HSV-1 protein ICP34.5 binds
the key autophagy factor Beclin 1 and
inhibits its function. The work by Shelly
et al. (2009) bypasses this problem
inherent to evolutionarily finely tuned
host-pathogen pairs: the authors em-
ployed a mismatch by using Drosophila
as a model system to study how auto-
phagy affects vesicular stomatitis virus
(VSV). This unlikely pair is not as remote
from real-life situations as it may appear
at first blush, given thatVSVnormally alter-
nates between arthropod vectors and
mammalian host and can grow in both
insect and mammalian cells.
Shelly et al. (2009) first showed that VSV
replicated inDrosophilaS2 cells. The virus
released from S2 cells was found to repli-
cate in mammalian cells, thus showing
that the virus produced in this system is
functional without an apparent penalty to
its host range. Having established this,
Shelly et al. (2009) first knocked down
three of the key autophagy factors, Atg1,
Atg5, and Atg8a, and later on, a panel of
other Atg factors (Atg1, Atg2, Atg4, Atg6,
Atg7, Atg8b, and Atg9) and showed that
this increased VSV production in infected
cells. The changes detected by two
measures, including viral titers, were
small but statistically significant. Further-
more, the authors found that VSV induced
autophagy in Drosophila cells. Interest-
ingly, this induction occurred whether
the cells were infected with replication-
competent or UV-inactivated VSV. This
gave authors a hint that replicationy 30, April 17, 2009 ª2009 Elsevier Inc. 479
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autophagy; such a finding is of signifi-
cance because in experiments by others,
using different virus-dendritic cell pairs,
viral replication was a key to the engage-
ment of the autophagic pathway (Lee
et al., 2007). As an upshot from these
observations, Shelly et al. (2009) consid-
ered the possibility that a preformed viral
molecule (rather than a replicating virus)
acted as a pathogen-associated mole-
cular pattern (PAMP) possibly stimulating
an unidentified PRR. This is a reasonable
assumption because PAMPs and PRRs
are known to engage the autophagoso-
mal pathway in a variety of ways: by
inducing autophagy upon PRR stimula-
tion with PAMPs (Deretic, 2009), by em-
ploying autophagy as a topological
inversion device to deliver PAMPs to
endosomal PRRs (Lee et al., 2007), or
even by using autophagy to dampen
potentially excessive response of RIG-I-
like receptors (RLRs) in the context of
infection with VSV (Tal et al., 2009). Shelly
et al. (2009) went on to challenge GFP-
LC3 (used as a probe for autophagy)
reporter cells with VSV glycoprotein G
(VSVG)-induced membrane blebs or
vesicular particles and observed that this
material can induce formation of GFP-
LC3 puncta, which are conventionally
taken as a sign of autophagosome forma-
tion. On the basis of these observations,
the authors proposed that VSVG is
a PAMP that can induce autophagy,
although the precise composition of
PAMP and the identity of its cognate
PRR remained to be established. A hint
for a likely participation of TLRs comes
from the mammalian hosts pointing to
TLR4 as a PRR for VSVG. This dovetails
with the reports that TLR4 can induce
autophagy (Xu et al., 2007).
Next, Shelly et al. (2009) used the
VSV-Drosophila model to demonstrate a
requirement for autophagy to render
VSV infection nonpathogenic in adult flies.
When flies, which normally survive infec-
tion with VSV, were depleted of Atg8,
90% of them died by day 12 after infec-
tion. The virus in the Atg18-depleted flies
replicated to higher titers prior to lethality.
The authors went an extra mile and
showed that Atg7 or Atg12 depletion in
flies lead to similar phenotypes in terms
of lethality and viral replication in vivo,
albeit some variances vis-a`-vis Atg18
were observed. Potentially relevant for480 Immunity 30, April 17, 2009 ª2009 Elsevany therapeutic ideas that may emanate
form this work, Shelly et al. (2009) showed
that there was a role for the Akt pathway
(and probably Tor) in controlling the virus
in infected flies. In an elegant conclusion
to the paper, the authors resorted to
a clever experimental trick bypassing
some difficulties inherent to the system.
The authors gave flies insulin (which acti-
vates Akt and inhibits autophagy in
many cells) and showed that infection
with the virus abrogated insulin-depen-
dent Akt activation. This observation
suggests that signaling leading to induc-
tion of autophagy in response to VSV
infection also includes inhibitory effects
on Akt. Thus, there seems to be a link
between atophagy induction and inhibi-
tion of pathways associated with nutrition
and growth-factor-dependent increase in
cellular biomass (Figure 1). It brings a new
meaning to the myth ‘‘feed a cold and
starve a flu.’’
Figure 1. Autophagy in Antiviral Immunity
Induction of autophagy as a cell-autonomous anti-
viral defense in metazoans may require simulta-
neous stimulation with PRR agonists and inhibition
of the Akt pathway. Autophagy, as demonstrated
by Shelly et al. (2009), controls VSV in vivo. This
process occurs via viral PAMP-dependent induc-
tion of autophagy through a PRR (possibly TLR).
Nutritional signals, such as insulin, can counteract
autophagy induction by stimulating Akt and Tor
(Tor inhibits autophagy), but Shelly et al. (2009)
observed that during viral PAMP stimulation of
autophagy, Akt pathway was inhibited by an
unknown mechanism (dashed line); this could be
related to the feedback loops known to exist
between Tor targets and Akt function (not de-
picted).ier Inc.An interesting question arises as to
whether these systems are coordinated
in all organisms and whether this is
perhaps a key primordial reaction of in-
fected eukaryotic or metazoan cell to
limit growth of microbes by simulta-
neously blocking protein synthesis and
inducing cell-autonomous systems that
can capture and degrade intracellular
pathogens or their biosynthetic interme-
diates. If so, this would resonate well
with the studies by Levine and
colleagues (Orvedahl et al., 2007), where
HSV-1 was found to have evolved ways
to inhibit both of these defense mecha-
nisms (represented by PKR and Beclin
1) in the mammalian host. Perhaps this
dual action will become a common
theme in the context of autophagy and
host-pathogen interactions. Further-
more, this could be an Achilles’ heel of
this defense process, as seen with the
stimulation of the Akt pathway down-
stream of IL-4 and IL-13, when Th2
cell response inhibits autophagic control
of Mycobacterium tuberculosis (Harris
et al., 2007).
In conclusion, the study by Shelly et al.
(2009) used a clever approach to unmask-
ing the role of autophagy in vivo. A ques-
tion arises: can such processes be
observed in finely tuned host-pathogen
pairs without disarming the microbe of
its antiautophagic adaptations? The
answer is yes: the first paper that showed
that autophagy control viruses comes
from a study in plants—in which Beclin 1,
Atg3, and Atg7 were necessary to limit
tobacco mosaic virus in the infected
leaves. However, it is easier to appreciate
this role of autophagy if the pathogen and
the host are not perfectly matched. In vivo
studies akin to those by Shelly et al. (2009)
in Drosophila have shown that autophagy
controls bacterial infections (e.g., Listeria)
(Yano et al., 2008). M. tuberculosis falls
prey to autophagy in human cells (Gutier-
rez et al., 2004). Interestingly, M. tuber-
culosis, albeit a big-time scourge of
human population, has had evolutionarily
speaking a relatively short time to fully
adapt to its host given the slow doubling
time. This seems to bring to the fore one
of the potential take-home messages (if
not a rule) that can be extracted from the
study by Shelly et al. (2009): the ease of
detecting autophagic control of intracel-
lular microbes increases if the host-path-
ogen pair under study has not yet reached
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Previewsan evolutionary equilibrium, i.e., before
a pathogen has had a chance to perfect
defenses against autophagy.
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